You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

Type 2 Inflammation

ADVENT at NAPNAP 2025

Join experts Jonathan Spergel, MD, PhD, Wanda Phipatanakul, MD, MS, and Jerry Ellen Schonfeld, CPNP, at an educational symposium as they investigate the role of type 2 inflammation in pediatric diseases. The speakers will also discuss the difficulties in diagnosis and burdens patients and their families face.

MD, PhD

Jonathan Spergel +2 more

Past event

12March2025

Location

Hyatt Regency Chicago - Grand Hall K-L

151 East Wacker Drive, Chicago, IL 60601

Symposium Details

March 12

Unmasking Type 2 Inflammation: Understanding Clinical Presentation in Pediatric Inflammatory Diseases

Uncover how multiple pediatric atopic diseases have a shared type 2 inflammatory profile with experts, Jonathan Spergel, MD, PhD, Wanda Phipatanakul, MD, MS and Jerry Ellen Schonfeld, CPNP, at NAPNAP 2025.

Agenda

Welcome

Jonathan Spergel, MD, PhD

Type 2 Inflammation Underpins Multiple Pediatric Diseases

Jonathan Spergel, MD, PhD

Putting a Face to the Disease in the Clinic — Cases and Discussion

Jonathan Spergel, MD, PhD, Wanda Phipatanakul, MD, MS, and Jerry Ellen Schonfeld, CPNP

Panel Discussion: Patient Burdens and Comorbidities

All Faculty

Audience Q&A

All Faculty

Location

Hyatt Regency Chicago - Grand Hall K-L

151 East Wacker Drive, Chicago, IL 60601

Speakers

Allergy/Immunology

MD, PhD

Jonathan Spergel

Professor of Pediatrics | Perelman School of Medicine, University of Pennsylvania; Chief of Allergy Section and Director of the Center for Pediatric Eosinophilic Disorders | Children’s Hospital of Philadelphia, Pennsylvania, United States

Pulmonology

MD, MS

Wanda Phipatanakul

Director of the Division of Immunology Research Center | Boston Children’s Hospital, Massachusetts, United States

Dermatology

CPNP

Jerry Ellen Schonfeld

Certified Pediatric Nurse Practitioner

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: SpainChange country/region